HRAS - HRas proto-oncogene, GTPase Gene

Also Known as H-Ras

Species: Bos taurus

Gene Type: protein coding
Gene ID: 100298939

About HRAS

Primary_assembly 29: 50,756,430-50,765,200 forward strand.ARS-UCD1.2:CM008196.2

This gene has 3 transcripts (splice variants), 223 orthologues and 38 paralogues.

HRAS Products (2)

mRNA Protein Name
NM_001242347.1 NP_001229276.1 GTPase HRas isoform 2
NM_001242346.1 NP_001229275.1 GTPase HRas isoform 1

HRAS Protein Structure

H_N_K_Ras_like

H_N_K_Ras_like: cd04138 (2 - 163)

  • 0
  • 100
  • 189 a.a.
Protein Preferred Names Protein Names

GTPase HRas

  • GTPase HRas (Transforming protein p21) (H-Ras-1) (c-H-ras)

  • Harvey ras 1

  • p19 H-RasIDX protein

  • v-Ha-ras Harvey rat sarcoma viral oncogene homolog

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (6)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0660 Eicosapentaenoic Acid Activator 98.09% Yes
HY-15136 Lonafarnib 99.85% Yes
HY-B0984 Fendiline hydrochloride 99.78% Unkown
HY-B0984A Fendiline 99.41% Unkown
HY-B0984R Fendiline hydrochloride (Standard) 99.76% Unkown
HY-W011269 Eicosapentaenoic Acid sodium Activator 95.78% Unkown

Clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Phase
HY-176785S MCB-294 98.04% Phase 4
HY-148439 Daraxonrasib Inhibitor 99.96% Phase 3
HY-173632 AMG410 Inhibitor 99.75% Phase 1
HY-16111 BMS-214662 Inhibitor 99.86% Phase 1
HY-16373 CP-609754 Inhibitor 99.49% Phase 1

Pre-clinical Phase

Bioactive Molecules (48)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-156498 RMC-7977 Inhibitor 99.48% Unkown
HY-100002 ML162 99.52% Unkown
HY-122862 RAS inhibitor Abd-7 Inhibitor 99.57% Unkown
HY-176786 MCB-36 98.43% Unkown
HY-113849 MLS-573151 Inhibitor 99.66% Unkown
HY-123242 FTI-2153 Inhibitor 99.77% Unkown
HY-125904 4-Hydroxyretinoic acid ≥95.0% Unkown
HY-15879 LB42708 ≥99.0% Unkown
HY-175870 Eras-4001 Inhibitor 98.27% Unkown
HY-161233A BTX-6654 formate 98.85% Unkown
HY-181420A BBO-11818 99.77% Unkown
HY-15873A FTI 276 TFA Inhibitor 98.31% Unkown
HY-145962A MRTX-EX185 formic Inhibitor 97.15% Unkown
HY-N10336 Notoginsenoside R4 99.90% Unkown
HY-168847 INCB159020 Inhibitor / Unkown
HY-115489A GGTI-286 TFA Inhibitor / Unkown
HY-16111A BMS-214662 hydrochloride Inhibitor 98.54% Unkown
HY-115489 GGTI-286 Inhibitor / Unkown
HY-145962 MRTX-EX185 Inhibitor / Unkown
HY-161233 BTX-6654 / Unkown
HY-117935 GGTI-286 hydrochloride Inhibitor / Unkown
HY-123242A FTI-2153 TFA Inhibitor 98.41% Unkown
HY-RS06355 Hras Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-106603 Sulofenur / Unkown
HY-116428 L-744832 / Unkown
HY-117807 A-176120 Inhibitor / Unkown
HY-120763 LB42908 Inhibitor / Unkown
HY-122685 UC-773587 Inhibitor / Unkown
HY-128762 ML256 Inhibitor / Unkown
HY-134505 Avicin G Inhibitor / Unkown
HY-151263 G4/HDAC-IN-1 / Unkown
HY-15136B (Rac)-Lonafarnib / Unkown
HY-173632A AMG410 diTFA Inhibitor / Unkown
HY-175870A (7R)-Eras-4001 Inhibitor 97.02% Unkown
HY-176349S HRAS, Arg-13C6,15N4, Lys-13C6,15N2 / Unkown
HY-181420 (S,R,S)-BBO-11818 / Unkown
HY-182411 KRAS-IN-56 Inhibitor / Unkown
HY-183931 NPA101.3 Inhibitor / Unkown
HY-B0660S1 Eicosapentaenoic acid 1,2,3,4,5-13C5 Activator / Unkown
HY-B0660S2 Eicosapentaenoic acid-d10 / Unkown
HY-RS06354 HRAS Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06356 Hras Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W1126467 RAS-IN-5 Inhibitor / Unkown
HY-114894 2C07 Inhibitor / Unkown
HY-120271 GGTI-297 Inhibitor / Unkown
HY-B0660A Eicosapentaenoic acid metformin Activator / Unkown
HY-N10379 19-epi-Scholaricine 99.14% Unkown
HY-N20754 DHA-free EPA oil / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens HRAS NCBI NCBI:3265